Predictors of intra-abdominal coagulopathic hemorrhage after living donor liver transplantation  by Kao, Man-Ling et al.
lable at ScienceDirect
International Journal of Surgery 11 (2013) 1073e1077
ORIGINAL RESEARCHContents lists avaiInternational Journal of Surgery
journal homepage: www.journal-surgery.netOriginal researchPredictors of intra-abdominal coagulopathic hemorrhage after living
donor liver transplantation
Man-Ling Kao a,f, Ping-Yi Lin b,f, Chia-En Heish c, Chen-Te Chou d, Kuo-Hua Lin c,
Chih-Jan Ko c, Chia-Cheng Lin c, Yao-Li Chen c,e,*
aDepartment of Surgical Critical Care, Changhua Christian Hospital, Changhua, Taiwan, ROC
b Transplant Medicine & Surgery Research Centre, Changhua Christian Hospital, Changhua, Taiwan, ROC
cDepartment of Surgery, Changhua Christian Hospital, Changhua, Taiwan, ROC
dDepartment of Medial Imaging, Changhua Christian Hospital, Changhua, Taiwan, ROC
e School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, ROCa r t i c l e i n f o
Article history:
Received 19 June 2013
Received in revised form
30 September 2013
Accepted 8 October 2013
Available online 22 October 2013
Keywords:
Living donor liver transplantation
Coagulopathic hemorrhage
Hepatic artery
Cold ischemia time* Corresponding author. Changhua Christian Hospit
Taiwan, ROC. Tel.: þ886 04 7238595; fax: þ886 04 72
E-mail addresses: 31560@cch.org.tw, ylchen.cch@g
f Equally contributed.
1743-9191/$ e see front matter  2013 Surgical Asso
http://dx.doi.org/10.1016/j.ijsu.2013.10.004a b s t r a c t
Background: Results of preoperative conventional coagulation assays are a poor predictor of hemorrhage
after liver transplantation. In this study, we evaluated the factors that are predictive of intra-abdominal
coagulopathic hemorrhage after living donor liver transplantation surgery.
Methods: During the period from January 2009 to December 2012, 118 adults underwent living donor
liver transplantation (LDLT) in our institution. Of those patients, 18 (15.3%) developed intra-abdominal
coagulopathic hemorrhage (n ¼ 7) or hemorrhage due to non-coagulopathic causes (n ¼ 11) that
required emergency medical, radiological, or surgical intervention within the ﬁrst month after LDLT.
Possible predictors of postoperative coagulopathic hemorrhage included donor-related factors, age, body
mass index, MELD score, INR value, intra-operative blood transfusion, graft/recipient weight ratio,
anhepatic phase, cold ischemia time, operative time, APACHE II score, onset of re-bleeding, and hemo-
globin levels during rebleeding episodes.
Results: There were no differences in any of the variables between the two groups (coagulopathic and
noncoagulopathic hemorrhage) except for cold ischemia time. We found that cold ischemia time was
signiﬁcantly longer in patients with postoperative coagulopathic hemorrhage (160.50  45.02 min) than
in patients with hemorrhage due to non-coagulopathic causes (113.55  29.31 min; P ¼ 0.027).
Conclusion: Prolonged cold ischemia time is associated with postoperative intra-abdominal coagulo-
pathic hemorrhage in patients after LDLT. It is, therefore, necessary to shorten the cold ischemia time in
order to reduce the risk of postoperative intra-abdominal hemorrhage due to coagulopathic causes.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Liver transplantation is the only treatment available for patients
with end-stage liver disease (ESLD).1 Although liver transplantation
is a curative treatment for most patients with ESLD, the shortage of
deceased donor organs continues to be the main obstacle in the
treatment of these patients.2 Fortunately, with improvements in
medical knowledge, surgical skills, and radiological techniques,
living donor liver transplantation (LDLT) is now an option for many
patients with ESLD. However, LDLT is associated with a number ofal, 135 Nansiao St., Changhua,
28289.
mail.com (Y.-L. Chen).
ciates Ltd. Published by Elsevier Ltpost surgical complications that contribute to hospital mortality
such as portal hypertension with various degrees of coagulopathy.3
Hemorrhage due to coagulopathy often manifests as diffuse oozing
at the operative site. Postoperative intra-abdominal bleeding, due
to vascular complications or disseminated intravascular coagulop-
athy due to underlying diseases may result in catastrophic conse-
quences. It has been reported that 7% of patients who undergo LDLT
experience an intra-abdominal bleed and that 24% of those patients
require re-exploration soon after transplant.4 Although the mech-
anism of bleeding is multifactorial, non-surgical etiologies such as
abnormalities of the hemostatic system can contribute to bleeding
after liver surgery. Failure to surgically control bleeding vessels at
the operative site is the most frequent cause of postoperative
bleeding, which can manifest as hemorrhage at the operative site
with expanding hematoma or excessive blood in surgical drains or
wound dressings. Thus, patients should undergo studies for thed. All rights reserved.
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factors, in platelet number and function, in hematocrit, blood vol-
ume, and body temperature, and should undergo proper treatment
for any underlying infection.5 Several investigators have shown
that the results of preoperative conventional coagulation assays are
a poor predictor of hemorrhage after liver transplantation. In
addition, correction of prolonged prothrombin time with recom-
binant factor VIIa has not been shown to lead to a reduction in
blood loss or transfusion in patients undergoing liver surgery.6
Suddendrainage of freshblood fromthedrainage tubeoranacute
decrease in hemoglobin level with or without systemic hypotension
suggests the presence of intra-abdominal bleeding and requires
emergency exploratory laparotomy. However, the clinical presenta-
tion of hemorrhage is usually nonspeciﬁc, consisting mainly of
localized pain and a falling serum hematocrit.7 Although Doppler
sonography combinedwith computed tomography (CT) is crucial for
establishing a diagnosis of complications in hepatic vessels,8e10 the
correct diagnosis cannot be made with imaging examination alone.
Thus, it is essential to understand the clinical and hematologic pa-
rameters relevant to postoperative intra-abdominal hemorrhage. In
this study, we evaluated the predictors of postoperative intra-
abdominal coagulopathic hemorrhage in patients after LDLT.
2. Materials and methods
2.1. Patients
This was a cross-sectional retrospective study. During the period
January 2009 to December 2012, 118 adult patients with ESLD un-
derwent right lobe LDLTat the Changhua Christian Hospital. Of those
patients, 18 developed postoperative intra-abdominal hemorrhage
within the ﬁrst month after surgery andwere enrolled in the present
study (Fig. 1). Surgical bleeding after liver transplantation was
deﬁned as bleeding at the vascular anatomotic site, bleeding in the
splenic hilum or stump of the hepatoduodenal ligament, bleeding inFig. 1. The studythe para inferior vena cava space or right subsplenic area, bleeding in
the abdominal wound, or bleeding at the surgical site requiring re-
operation. Non-surgical bleeding was deﬁned as oozing or bleeding
at an extrasurgical site (hemoglobin drop 2 g/dL).
The study protocol was approved by the hospital’s institutional
review board.
2.2. Clinical data
All clinical data were obtained through chart review. Donor-
related factors such as age and steatosis grades were evaluated.
Before surgery, patients were evaluated for liver disease severity
(Model for End-Stage Liver Disease, MELD score), coagulation
function (International Normalized Ratio, INR), and the presence of
hepatitis B virus (HBV), hepatitis C virus (HCV), and alcoholic
hepatitis. The intra-operative variables included graft/recipient
weight ratio (GRWR; %), operative time, intra-operative blood
transfusion (units of packed red blood cells; PRBC), units of fresh
frozen plasma (FFP), units of platelets and units of cryoprecipitate
transfused, warm and cold ischemia time, and anhepatic phase.
Postoperative variables included acute physiologic and health
evaluation (APACHE) II score, onset of re-bleeding, re-bleeding
blood loss, international normalized ratio (INR) value, hemoglobin
level, blood pressure at onset of re-bleeding, and the presence of
abdominal compartment syndrome.
2.3. Measurements
Clinical criteria were used in addition to imaging studies to
determine the presence of hemorrhage. For example, patients who
showed signs of overt bleeding combined with a hemoglobin drop
2 g/dL requiring transfusion and patients with drainage of
150mL per hour of fresh blood through a Jackson-Pratt drain for at
least 2 h, or intra-abdominal pressure (IAP) > 20 mm Hg combined
with a drop in systolic blood pressure <90 mm Hg, and tachycardiapopulation.
Table 1
Sites of intra-abdominal hemorrhage after LDLT due to coagulopathy (group 1) and
due to non-coagulopathic causes (group 2).
Location Group 1 (n ¼ 7) Group 2 (n ¼ 11)
Retrohepatic region 1 e
Subphrenic region 2 e
Retroperitoneal region 2 e
Splenic artery 1 e
Abdominal wall 1 e
Hepatic artery e 6
Inferior vena cava e 2
Portal vein e 1
Splenic artery e 1
Adrenal gland e 1
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combined with CT. Hemorrhage was then deﬁned as coagulopathic
or noncoagulopathic after an exploratory laparotomy was per-
formed. Doppler sonographyand abdominal CTscanswere obtained
within 24 h after the development of signs of intra-abdominal
bleeding. Doppler sonographic examinations were performed by
an experienced gastroenterologist at the patient’s bedside. CT im-
ages of the liver were obtained with a 16-slice multi-detector CT
scanner (Lightspeed Ultra 16, GE Medical Systems, Milwaukee, WI,
USA) using the following parameters: a gantry rotation time of 0.8 s
for each phase; a 5-mm section thickness; 27.5-mm/s table speed;
120 kVp; and 160e440 mA. Patients were imaged in a craniocaudal
direction. Nonionic contrast medium (Omnipaque 350, General
Electric Healthcare, Princeton, NJ, USA) was administered at a total
dose of 100 mLe120 mL with an injection rate of 3 mL/s through a
20-gauge venous cannula placed in the antecubital vein. Scanning
was started with a 10-s scan delay (about 25e30 s after injection of
the contrast agent) for the hepatic arterial phase after the attenua-
tion value of the aorta reached 120 HU. Equilibrium-phase images
were acquired approximately 180e200 s after injection of the
contrast agent. The abdominal CT scans were reviewed by two ra-
diologists who specialize in abdominal imaging.
2.4. Statistical analysis
Data were recorded in a computer database. Possible predictors
of postoperative coagulopathic hemorrhage included age, donor-
related factors, body mass index, MELD score, INR value, intra-
operative blood transfusion (PRBC), GRWR, units of FFP, units of
platelets, units of cryoprecipitate transfused, anhepatic phase, cold
ischemia time, operative time, APACHE II score, onset of re-
bleeding, and hemoglobin levels at re-bleeding. We used the chi-
square test or Fisher’s exact test for categorical comparisons of
data and the ManneWhitney U-test to determine differences in the
means of continuous variables. A P-value less than 0.05 was
considered to indicate statistical signiﬁcance. All statistical analyses
were performed with the statistical package SPSS for Windows
(Version 16.0, SPSS Inc; Chicago, IL, USA).
3. Results
During the studyperiod,18patients (mean age, 53.5 years; range,
43e70 years) developed intra-abdominal hemorrhage within one
month after LDLT. In the majority of patients (14 of 18; 78.8%),Fig. 2. (A) Postoperative intra-abdominal hemorrhage attributed to coagulopathy; (B) Pabdominal bleeding occurred within 10 days after transplantation.
In two patients, bleeding occurred within 14 days, in one patient
bleeding occurred 15 days after surgery, and in one patient bleeding
was noted 22 days after the operation. Of the 18 patients who
developed hemorrhage, 13 (72.2%) were men. Most of the donors in
this study were young and had healthy liver function. Approxi-
mately one-third (6 of 18; 33.3%) of the donors had fatty liver with
liver steatosis grades ranging from 1 to 3. The distribution of high-
density ﬂuid accumulation in these patients is shown in Fig. 2. Pa-
tients were stratiﬁed into one of two groups depending onwhether
they developed hemorrhage due to coagulopathy (group 1, n¼ 7) or
hemorrhage due tonon-coagulopathic causes (group2,n¼11). Sites
of intra-abdominal hemorrhage are shown in Table 1. Bleeding sites
in patients in group 1 included the retrohepatic region (n ¼ 1), the
subphrenic region (n¼ 2), the retroperitoneal region (n¼ 2), splenic
artery (n ¼ 1), and the abdominal wall (n ¼ 1). In group 2, bleeding
sites comprised the hepatic artery (n ¼ 6), the inferior vena cava
(n ¼ 2), the portal vein (n ¼ 1), the splenic artery (n ¼ 1), and the
adrenal gland (n ¼ 1). The clinical features of the two groups of
patients are shown in Table 2. There were no signiﬁcant differences
between the two groups in donor related factors, age, body mass
index (BMI), MELD score, preoperative INR value, intra-operative
blood transfusion, units of fresh frozen plasma, units of platelets,
units of cryoprecipitate transfused, GRWR, anhepatic phase, oper-
ative time, APACHE II score, onset of re-bleeding, or hemoglobin
levels at the time of re-bleeding. However, cold ischemia time was
signiﬁcantly longer in patients with post-operative coagulopathic
hemorrhage (160.50 45.02min) than inpatientswithhemorrhage
due to non-coagulopathic causes (113.55  29.31 min; P ¼ 0.027).
Our results show that prolonged cold ischemia time is associatedostoperative intra-abdominal hemorrhage attributed to non-coagulopathic causes.
Table 2
Comparisons of demographic and clinical features of patients with intra-abdominal hemorrhage after LDLT.
Variables Group 1
n ¼ 7
Group 2
n ¼ 11
P Total
N ¼ 18
Age; yr (SD) 51.29 (9.16) 55.00 (6.34) 0.256 53.56 (7.53)
Gender (%) Female 2 (28.6) 3 (27.3) 1 5 (27.8)
Male 5 (71.4) 8 (71.4) 13 (72.2)
BMI (SD) 25.71 (4.46) 24.18 (4.49) 0.439 24.78 (4.41)
Age of donor; yr (SD) 32.57 (14.27) 28.00 (6.16) 0.820 29.78 (9.97)
Donor steatosis grades 0 4 (57.1) 8 (72.7) 0.463 12 (66.7)
1 2 (28.6) 2 (18.2) 4 (22.2)
2 0 (0) 1 (9.1) 1 (5.6)
3 1 (14.3) 0 (0) 1 (5.6)
GRWR; % (SD) 0.994 (0.201) 0.967 (0.112) 0.364 0.978 (0.148)
MELD score (SD) 19.14 (9.49) 18.09 (12.54) 0.586 18.50 (11.16)
INR (SD) 1.94 (0.91) 1.84 (1.24) 0.341 1.88 (1.09)
Intra-operative blood transfusion;
Packed RBC; units
(SD) 15.71 (11.22) 12.73 (10.93) 0.716 13.89 (10.81)
FFP; units (SD) 14 (7.75) 10.18 (8.36) 0.386 11.67 (8.12)
Platelet; units (SD) 12 (12) 8.18 (12.08) 0.495 9.67 (11.85)
Cryoprecipitate; units (SD) 0 (0) 2.18 (7.24) 0.425 1.33 (5.66)
Anhepatic phase (SD) 67.86 (45.62) 44.09 (22.56) 0.113 53.33 (34.29)
Cold ischemia time; min (SD) 160.50 (45.02) 113.55 (29.31) 0.027 130.12 (41.29)
Operative time; min (SD) 484.29 (86.19) 457.73 (95.30) 0.586 468.06 (90.23)
APCHE II score (SD) 22.86 (7.24) 18.09 (8.67) 0.339 19.94 (8.27)
Re-bleeding time; days (SD) 10.00 (6.98) 5.45 (4.08) 0.145 7.22 (5.67)
Hb at re-bleeding; gm/dl (SD) 8.71 (2.22) 7.67 (1.07) 0.317 8.08 (1.64)
Abbreviations: BMI: body mass index; GRWR: graft/recipient weight ratio; MELD score: model of end liver disease; INR: international normalized ratio; Fresh Frozen Plasma:
FFP; Hb: hemoglobin.
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patients after LDLT.4. Discussion
Although the overall outcomes of patients after liver trans-
plantation have improved, early graft failure remains a serious
concern because it is associated with high rates of morbidity and
mortality.11 A number of studies have reported that donor-related
factors such as age and steatosis grades can affect post-transplant
outcomes.12,13 Most of the donors in this study were young and
had healthy liver function; thus, there were no signiﬁcant differ-
ences between patients with hemorrhage due to coagulopathy and
patients with hemorrhage due to non-coagulopathic causes. The
risk of intra-abdominal coagulopathic hemorrhage and hemor-
rhage due to iatrogenic causes is high during the early post-
transplantation period. The incidence of postoperative vascular
complications among recipients ranges from 11.8% to 13.0% after
LDLT,14,15 and the incidence of arterial complications has been re-
ported to range from 6.5% to 9.1%.16,17 Arterial complications,
especially those occurring during the early postoperative period,
frequently require laparotomy, re-transplantation, or surgical
reconstruction. Jung et al. reported that the hepatic artery was the
most frequent site of bleeding requiring laparotomy among 94
patients with evidence of abdominal hemorrhage after orthotopic
liver transplantation.18 Although CT is crucial for establishing a
diagnosis of complications in hepatic vessels, it is important to
understand the predictors of postoperative intra-abdominal coa-
gulopathic hemorrhage.7 In the present study, we found that pro-
longed cold ischemia timewas associated with postoperative intra-
abdominal coagulopathic hemorrhage.
After liver resection, grafts are stored on ice at 0 Ce4 C. The
length of time that grafts are stored on ice varies depending on the
amount of time it takes to perform the recipient hepatectomy. It has
been reported that 10% of early transplant failures are due to liver
ischemiaereperfusion injury.19 Prolonged hepatic allograft cold
ischemia time (i.e. >12 h) has been shown to signiﬁcantly increase
the rate of graft loss and the rate of primary nonfunction.20According to the results of a recent meta-analysis, maximum pa-
tient and graft survival rates were associated with a cold ischemia
time ranging from 7.5 to 12.5 h.21 Therefore, additional efforts
should be made to minimize cold ischemia time.22
In conclusion, prolonged cold ischemia time is associated with
postoperative intra-abdominal coagulopathic hemorrhage in pa-
tients after LDLT. It is, therefore, necessary to shorten the cold
ischemia time in order to reduce the risk of postoperative intra-
abdominal hemorrhage due to coagulopathic causes.
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